Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China22 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DV Plus Toripalimab With Cetirizine and Mecobalamin Pretreatment in Patients With Locally Advanced Unresectable or Metastatic Bladder Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Not yet recruiting | Phase 1 | 2026-10-01 | NCT07853053 | |
| A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 1 | 2026-09-01 | NCT07798284 | |
| A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-08-28 | NCT07747857 | |
| OPtimizing REperfusion by Primary Intra-Arterial ThRomboLysis for Medium Vessel Occlusion | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-08-24 | NCT07137832 | |
| Research on the Development and Validation of Personalized Exercise Prescription System for Breast Cancer Patients Based on Large Language Models | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Not stated | 2026-08-17 | NCT07767565 | |
| Development of an AI-Agent for Urological Disease Diagnosis and Treatment | Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Urinary Calculi, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, urolithiasis | Recruiting | Not stated | 2026-07-23 | NCT07721935 | |
| Research on the Development and Validation of Personalized Exercise Prescriptions for Breast Cancer Patients Based on Large Language Models | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not stated | 2026-06-02 | NCT07619781 | |
| A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy | Pancreatic Ductal Adenocarcinoma (PDAC) | Recruiting | Phase 1 / Phase 2 | 2026-05-26 | NCT07235202 | |
| Ultrasound Monitoring of Clipped Lymph Nodes to Predict Axillary Response After Chemotherapy in Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Not stated | 2026-05-19 | NCT07596472 | |
| Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 3 | 2026-05-08 | NCT07569757 | |
| Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC | Lymph Node Metastasis, Lymphatic Metastasis, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bladder transitional cell carcinoma, neoplasm | Enrolling by invitation | Phase 1 | 2026-04-22 | NCT07353294 | |
| A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer | HER2-positive Breast Cancer | Recruiting | Phase 3 | 2026-03-27 | NCT07043725 | |
| Pedicled Lateral Chest Wall Lymph-Adipofascial Flap to Prevent Arm Lymphedema After Breast Cancer Surgery | Breast Cancer Lymphedema, Hemic and Lymphatic Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, lymphatic system disorder, lymphedema, neoplasm, skin disorder | Not yet recruiting | Not applicable | 2026-02-17 | NCT07415200 | |
| A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor | Solid Tumor | Recruiting | Phase 1 | 2026-01-15 | NCT07275242 | |
| Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2025-12-16 | NCT07092709 | |
| A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors | Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2025-09-02 | NCT04685226 | |
| Crisugabalin for Radiotherapy-Related Neuropathic Pain | Head and Neck Neoplasms, Neoplasms by Site, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, neoplasm, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder | Recruiting | Phase 2 | 2025-05-18 | NCT06766916 | |
| Clinical Features and Current Treatment of Primary Headache | Primary Headache | Not yet recruiting | Not stated | 2025-03-19 | NCT06883955 | |
| Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2023-06-22 | NCT05904964 | |
| YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 3 | 2023-04-05 | NCT05767892 | |
| Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2022-09-30 | NCT04263298 | |
| Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2020-11-30 | NCT04646759 |